Cargando…
Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis
BACKGROUND: Currently, the major treatment modalities of advanced melanoma are immune check point and mitogen-activated protein kinase (MAPK) pathway inhibitors. As lacking head-to-head randomizedcontrolled trials (RCTs) comparing immune check point and MAPK pathway inhibitors, we evaluated the effi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327485/ https://www.ncbi.nlm.nih.gov/pubmed/30626368 http://dx.doi.org/10.1186/s12885-018-5259-8 |